Beijing Hotgen Biotech Co., Ltd.

¥69.41As of Sun 8 Nov 2026, 12:00 UTC
SSE:688068Healthcare
Country China
PE (Fwd) •••
TSR 7Y CAGR 6.25%
Div yield —
ROE (15.16%)
Biotechnology
Beta (5Y) 0.51
PE TTM —
TSR TTM (56.62%)
Mkt cap ¥6.120B
ROIC (26.66%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
¥72
3.20%
(78.40%)
Hold 5|8|6|0|2
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
1.44
1.55
1.57
1.54
11.89%
13.84%
14.33%
13.58%
Revenue¥M
357.1
369.0
359.2
357.1
1.29%
7.08%
(0.97%)
0.83%
Peers (US$917.4M)
Cap (US$)
PE
925.5M
28.74x
Capital
TTM
5Y
10Y
Leveragex
1.111
0.279
0.266
EBIT/Intx
3.254
0.241
0.229
Own earn%
(84.81)
17.25
23.61
Sh yield%
14.38
36.71
31.41
Owners
Insiders/Inst%
10.54
28.18
Short interest%
5.09
SBC / revenue%
0.59
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
15
Op margin range%
8–14
$1 testx
0.0
Incr. ROIC%
0